Source: Beximco Pharmaceuticals Ltd. (BXPHARMA) | FY 2009-10 | Page 66

# Statement of Financial Position

**Reporting Period:** As at 31 December 2010  
**Reporting Currency & Multiplier:** BDT (Amount in Taka) | **Scale Multiplier:** 1.0

### ASSETS

| Particulars | Notes | 2010 | 2009 |
| --- | --- | --- | --- |
| Non-Current Assets |  | 18,150,731,678 | 12,975,195,529 |
| Property, Plant and Equipment- Carrying Value 4 (a) |  | 15,123,306,298 | 12,966,587,178 |
| Intangible Assets | 3.3 & 5 | 51,126,854 | 5,726,525 |
| Investment in Shares | 6 | 6,298,526 | 2,881,826 |
| Current Assets |  | 6,191,667,831 | 6,916,737,893 |
| Inventories | 7 | 1,983,809,444 | 1,722,953,284 |
| Spares & Supplies | 8 | 276,520,188 | 242,034,855 |
| Accounts Receivable | 9 | 821,356,439 | 694,111,730 |
| Loans, Advances and Deposits | 10 | 779,129,620 | 699,204,450 |
| Short Term Investment | 11 | 859,403,704 | 2,500,000,000 |
| Cash and Cash Equivalents | 12 | 1,471,448,436 | 1,058,433,574 |
| TOTAL ASSETS |  | 21,372,399,509 | 19,891,933,422 |
| EQUITY AND LIABILITIES |  |  |  |
| Shareholders' Equity |  | 15,974,086,451 | 10,885,706,614 |
| Issued Share Capital | 13 | 2,098,065,090 | 1,511,492,960 |
| Share Premium | 14 | 5,269,474,690 | 1,489,750,000 |
| Excess of Issue Price over Face Value of GDRs | 15 | 1,689,636,958 | 1,689,636,958 |
| Capital Reserve on Merger |  | 294,950,950 | 294,950,950 |
| Revaluation Surplus 4(b) |  | 1,534,645,820 | 1,617,361,714 |
| Retained Earnings |  | 5,087,312,943 | 4,282,514,032 |
| Non-Current Liabilities |  | 2,885,155,826 | 6,684,775,166 |
| Long Term Borrowings-Net off Current Maturity (Secured) | 16 | 1,902,150,733 | 1,924,933,065 |
| Fully Convertible, 5% Dividend, Preference Share |  | - | 4,100,000,000 |
| Liability for Gratuity & WPPF | 17 | 335,885,792 | 307,425,614 |
| Deferred Tax Liability | 18 | 647,119,301 | 352,416,487 |
| Current Liabilities and Provisions |  | 2,513,157,232 | 2,321,451,642 |
| Short Term Borrowings | 19 | 1,639,961,052 | 1,451,326,354 |
| Long Term Borrowings-Current Maturity | 20 | 348,860,443 | 308,820,056 |
| Creditors and Other Payables | 21 | 432,315,660 | 409,898,122 |
| Accrued Expenses | 22 | 90,512,178 | 79,094,905 |
| Dividend Payable |  | 1,507,899 | 1,727,724 |
| Income Tax Payable | 23 | - | 70,584,481 |
| TOTAL EQUITY AND LIABILITIES |  | 21,372,399,509 | 19,891,933,422 |